Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mechanistic 129 Xe MRI Study to Assess Therapeutic Response in Fibrotic Interstitial Lung Disease

NCT07786090 is registered in ClinicalTrials.gov with Dr. Grace Parraga as lead sponsor.

NCT NCT07786090
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07786090 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mechanistic 129 Xe MRI Study to Assess Therapeutic Response in Fibrotic Interstitial Lung Disease
Lead sponsor
Dr. Grace Parraga
Phase
Observational
Overall status
Not yet recruiting
Start date
November 30, 2026
Completion date
January 31, 2029
Enrollment
35 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fibrotic interstitial lung disease